Veeva Systems (NYSE:VEEV) (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management. In addition to application software, Veeva supplies industry-specific master data and reference information to support multichannel engagement and analytics. The company emphasizes configurable, compliance-focused solutions that aim to shorten development timelines, improve regulatory submissions, and streamline commercial execution for life sciences organizations.
Operating globally, Veeva serves customers across North America, Europe, Asia-Pacific and other regions, working with a range of organizations from small biotechnology firms to large multinational pharmaceutical companies. The firm was founded by Peter Gassner, who has played a central leadership role in its development. Veeva positions itself as a specialist provider for the regulated life sciences market, combining domain expertise with cloud technology to address the sector’s unique data, compliance and collaboration needs.
